Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis
International Journal of Molecular Sciences · 16.12.2023 · 24 (24) · 17538
DOI: 10.3390/ijms242417538 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.12.2023. Verfasst von Huimin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New…. Hauptthemen laut MEDLINE: Pomegranate, Colitis, Ulcerative, Lythraceae. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ulcerative colitis, an immune-mediated inflammatory disease of the gastrointestinal tract, places a significant financial burden on patients and the healthcare system. Recently, reviews of the pomegranate and the abundant medicinal applications of its ellagitannins, as well as its pharmacological action, phytochemicals, metabolism, and pharmacokinetics, have been completed. However, summaries on their anti-ulcerative colitis effects are lacking. Numerous preclinical animal investigations and clinical human trial reports demonstrated the specific therapeutic effects of pomegranate and the effect of its ellagitannins against ulcerative colitis. According to the literature collected by Sci-finder and PubMed databases over the past 20 years, this is the first review that has compiled references regarding how the rich ellagitannins found in pomegranate have altered the ulcerative colitis. It was suggested that the various parts of pomegranates and their rich ellagitannins (especially their primary components, punicalagin, and ellagic acid) can inhibit oxidant and inflammatory processes, regulate the intestinal barrier and flora, and provide an anti-ulcerative colitis resource through dietary management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin 301617, China.
- Tianjin Key Laboratory of TCM Chemistry and Analysis, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, West Area, Tuanbo New Town, Jinghai District, Tianjin 301617, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Ruan, J., Huang, J., Yang, D., Yu, H., Wu, Y., Zhang, Y., & Wang, T. (2023). Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis. International Journal of Molecular Sciences, 24(24), 17538. https://doi.org/10.3390/ijms242417538
Vancouver
Li H, Ruan J, Huang J, Yang D, Yu H, Wu Y, et al. Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis. International Journal of Molecular Sciences. 2023;24(24):17538. doi:10.3390/ijms242417538
BibTeX
@article{Li2023,
author = {Li, Huimin and Ruan, Jingya and Huang, Jiayan and Yang, Dingshan and Yu, Haiyang and Wu, Yuzheng and Zhang, Yi and Wang, Tao},
title = {Pomegranate (Punica granatum L.) and Its Rich Ellagitannins as Potential Inhibitors in Ulcerative Colitis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {24},
pages = {17538},
doi = {10.3390/ijms242417538}
}
EUVIMED